SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-24-189924
Filing Date
2024-07-31
Accepted
2024-07-31 16:06:33
Documents
96
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d674405d10q.htm   iXBRL 10-Q 2891846
2 EX-10.2 d674405dex102.htm EX-10.2 19363
3 EX-31.1 d674405dex311.htm EX-31.1 10356
4 EX-31.2 d674405dex312.htm EX-31.2 10346
5 EX-32 d674405dex32.htm EX-32 4334
  Complete submission text file 0001193125-24-189924.txt   13859936

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA teva-20240630.xsd EX-101.SCH 92916
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20240630_cal.xml EX-101.CAL 51531
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE teva-20240630_def.xml EX-101.DEF 610588
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20240630_lab.xml EX-101.LAB 629665
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20240630_pre.xml EX-101.PRE 640801
99 EXTRACTED XBRL INSTANCE DOCUMENT d674405d10q_htm.xml XML 3033161
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020
Business Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020 972 (3) 914-8213
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16174 | Film No.: 241161931
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)